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Abstract 
Introduction: Antioxidant agents such as cocoa could have some benefits in treatment of 
inflammation including periodontitis. The aim of this study was to investigate the effects of cocoa 
consumption on moderate chronic periodontitis. 
Materials &Methods: This single-blind randomized clinical trial study was performed on 40 
subjects who were randomly divided into two groups. Treatment group received 30 gr dark 
chocolate (78% cocoa) and control group received 22.5 gr white chocolate three times a day for 4 
weeks. Saliva samples were collected from patients at baseline and twenty-eight days after eating 
chocolate. Probing pocket depth (PPD), Gingival index (GI, Silness and Loe), Modified papillary 
bleeding index (MPBI, Barnett), Clinical attachment loss (CAL) were recorded at baseline and 
2nd, 4th, 6th, 8th weeks later in ramfjord teeth. Total antioxidant capacity (TAC) and lipid 
peroxidation of saliva were estimated by Ferric reducing antioxidant power (FRAP) and Tiuborbituric 
acid reactive substances (TBARS) methods. Data of clinical parameters were analyzed using t-test 
and repeated measures test. Biochemical parameters were analyzed using t-test. 
Results: Intra-group comparison of clinical parameters demonstrated significant decrease in both 
groups (p<0.0001) and inter-group comparison showed significant decrease of MPBI in treatment 
group, (p<0.03). MPBI and GI were significantly decreased in treatment group compared to the 
control in the weeks of 4th, 6th and 8th, according t-test (GI4, P=0.008-GI6, P=0.008-GI8, 
P=0.009), (MPBI4, MPBI6, MPBI8, P<0.0001). Treatment group showed the increase in FRAP, 
(p<0.00001) and decrease in TBARS, (P<0.015) which were statically significant in compare with 
control group. 
Conclusion: Consuming dark chocolate could increase TAC and decrease lipid peroxidation, 
gingival bleeding and inflammation. 
Keywords: Chronic periodontitis, Cacao, Polyphenols, Antioxidants, Saliva, Lipid peroxidation, 
Clinical trials, randomized 
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همزم تیتودًیرپ رب خلت تلاکش ییایمیشًیب ي یکیىیلک رثا  
 
نایباىج رفًلیو ،نایرگدير کىشير*ریدخ ٍمطاف ،ریمارًپ یدُم ،ایو مدقم ربکا یلع ،  
 
ٌدیکچ 
ٍمدقم: ًدَیرپ ِلوج زا باْتلا ىاهرد رد یدیاَف دًٌاَت یه َئاکاک ِلوج زا ىادیسکا یتًآ تابیکرت يیا زا فدّ .دٌضاب ِتضاد تیت
،ِعلاطه .دضاب یه طسَته يهسه تیتًدَیرپ رد َئاکاک فرصه ریثات یسررب 
:اَ شير ي داًم  یٍر رب رَک ِیَس کی یٌیلاب ییاهزآ راک کی00  ٍُرگ ٍد ِب یفداصت ترَص ِب ِک تسا ِتفرگ ترَص راویب00 
.دًدیدرگ نیسمت ُرفً  ىاهرد ٍُرگ00 ( خلت تلاکض مرگ87%  لرتٌک ٍُرگ ٍ )َئاکاک5/00 ،)َئاکاک ىٍدب( دیفس تلاکض مرگ  راب ِس
،زٍر رد  فرصه عٍرض زا سپ زٍر يیوتطّ ٍ تسیب ٍ ِعلاطه عٍرض ىاهز رد قاسب یاّ ًَِوً .دَوً تفایرد ِتفّ راْچ تده ِب
یا ِثل صخاض ،تکاپ گٌیبٍرپ كوع .دیدرگ یرٍآ عوج ىاراویب زا تلاکض(Loe and Silness)اض ، یسیرًَخ ِتفای رییغت صخ
 یرلایپاپ(Barnett)  سپ  نتطّ ٍ نطض ،مراْچ ،مٍد یاّ ِتفّ ،ِعلاطه عٍرض ىاهز رد یکیٌیلک یگدٌبسچ يتفر تسد زا ىاسیه ٍ
 ىآ زا یاًْادًد رد.دض یریگ ُزادًا درَفهر شٍر طسَت قاسب یدیپیل ىَیسادیسکا ٍ ىادیسکا یتًآ مات تیفرظFerric reducing 
antioxidant power (FRAP)   ٍTiuborbituric acid reactive substances (TBARS)  .دض یریگ ُزادًا 
 یاّ ىَهزآ اب یکیٌیلک یاّ رتهاراپ  زا لصاح یاّ ِتفایt-test   ٍRepeated measures test  زا لصاح یاّ ِتفای ٍ
 ىَهزآ اب ییایویضَیب یاّرتهاراپt-test رارل ِسیامه درَه ٍ ُدض سیلاًآ .تسا ِتفرگ 
:اَ ٍتفای دَب راداٌعه یراهآ ظاحل زا ٍُرگ ٍد رّ رد یکیٌیلک یاّ رتهاراپ یٍّرگ لخاد ِسیامه (0.0001>P ) يیب  ی ِسیامه رد
یکیٌیلک یاّ رتهاراپ یٍّرگ  صّاک ىاهرد ٍُرگ رد یرلایپاپ یسیرًَخ ِتفای رییغت صخاض  تسا ُداد ىاطً یراهآ ظاحل زا راد یٌعه
(0.03>Pغت ) تاریی  مراْچ یاّ ِتفّ رد یرلایپاپ یسیرًَخ ِتفای رییغت صخاض ٍ یا ِثل صخاض(0.008>Pنطض ،) 
(0.008>P.تسا ُدَب راد یٌعه ىاهرد ٍُرگ رد یراهآ ظاحل زا نتطّ ٍ )  رد یراداٌعه صیاسفا لرتٌک ٍُرگ اب ِسیامه رد ىاهرد ٍُرگ
( ىادیسکا یتًآ مات تیفرظ0.00001>Pراداٌعه صّاک ٍ  )( یدیپیل ىَیسادیسکا رد ی0.015>P.تسا ُداد ىاطً قاسب ) 
:یریگ ٍجیتو ،قاسب ىادیسکا یتًآ مات تیفرظ صیاسفا ِب رجٌه خلت تلاکض فرصه  صّاک ٍ قاسب یدیپیل ىَیسادیسکا صّاک
.ددرگ یه یا ِثل یسیرًَخ ٍ باْتلا 
:یدیلک ناگژاي ،اّ ىادیسکا یتًآ ،لٌَف یلپ ،َئاکاک ،يهسه تیتًدَیرپ ،یٌیلاب ییاهزآ راک ،یدیپیل ىَیسادیسکارپ ،قاسب یفداصت 
 
Introduction 
‏ Chronic periodontitis is a common inflammatory 
disease, which affects tooth-supporting tissue and is the 
major cause of tooth loss in adults. [1,2] The etiology of 
the disease is commonly related to the colonization of 
complex anaerobic (geram-negative) bacteria. 
[3]
 One 
of the mechanism distributions of periodontitis is 
production of reactive oxygen species (ROS). 
[4]
 For 
treatment of periodontal disease, mechanical 
approaches like scaling and root planning (SRP) and 
surgery have been widely used.  Nowadays antibiotics 
and Non-steroidal anti-inflammatory drugs have been 
used as medicament beside the mechanical procedures. 
[5,6]
  Antioxidants  agents could  have some benefits in 
suppression of ROS production. There are some 
investigations which show that antioxidant agents  
absorb locally, systemically, in daily diet and in 
conjunction with dentifrices inhibits oxidative 
destruction of periodontal disease. 
[7] 
 Lately, cocoa due  
 
to its polyphenol flavonoids content has became a  
material of interest as a therapeutic agent. 
[8]
 Cocoa is 
called the cocoa beans from the plant of Theobroma 
cacao. 
[9]
 Catechin and procyanidius are the main 
flavonoids in cocoa beans. 
[10, 11]
 More than 35% of 
chatechins are (-)-epicathechin. While (+)-chatechin, 
(+)- gallocatechin and (-)-epigallocate are the other 
compounds with lower amounts. 
[9,12,13] 
 Some of 
studies investigated probable positive effects of cocoa 
on human health. The results show that cocoa may be 
used as antioxidant, ant-inflammatory, anti- 
carcinogenic, anti-cariogenic, anti-bacteria and anti-
virus agent. 
[12-16]
 In addition, cocoa has beneficial 
effects on cardiovascular, immune and neural system 
and skin. 
[11,17-21]
 Tomofuji et al. showed   that cocoa-
enriched diet reduced the oxidative stress-induced 
periodontitis. 
[8]
 Mao et al. suggested that consumption 
of cocoa and dark chocolate could reduce the risk of 
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periodontal disease via regulation of cytokine 
secretion.
[12]
 Different studies pointed out the 
relationship between total antioxidant capacities 
(TAC), lipid peroxidation of saliva and periodontal 
status. 
[22-24]
 So, the aim of this study was to investigate 
the effects of dark chocolate consumption on these 
factors. Furthermore, the effects of dark chocolate 
consumption on improvement of periodontal clinical 
parameters have been evaluated. 
 
 
Methods 
Case selection: A single-blind randomized clinical 
trial study was performed on 40 subjects referred to 
department of periodontology, Faculty of Dentistry, 
Babol University of Medical Science .This 
investigation was approved by the Ethics Committee of 
Babol University of Medical Science and it was 
registered in Iranian Registry of Clinical Trials with 
IDNo:IRCT201309303813N3. Written informed 
consent form was signed by each patients that its 
included criteria were as follows: subjects who were 
able to cooperate with similar plaque index (silness and 
loe), having chronic moderate periodontitis, the age of 
30 to 50 years old, average of attachment loss from 3 to 
6mm, subjects without history of systemic disease, of 
sensitivity to cocoa, of its productive and digestive 
problems.  
Excluding criteria were as follows: subjects who 
received NSAIDs and antibiotics during last one 
month, nutritional and vitamin supplements, cocoa and 
its products used in their daily nutritional regiment, 
subjects who smoked, were under periodontal 
treatment during past 6 months and menopause 
women. 
Intervention: All patients received phase I periodontal 
treatment consist of oral hygiene instruction and SRP. 
In the next session, the patients with less than 30% 
plaque index participated in the current study. The 
patients were randomly divided into two groups. The 
first group and the second group received 30 gr dark 
chocolate 78% cocoa (Aidin Company, Tabriz, Iran) 
(table 1) and 22.5 gr white chocolate without cocoa 
(Aidin Compay, Tabriz, Iran) (table 2) three times a 
day for 4 weeks, respectively. Chocolates were packed 
in encoded pockets. Furthermore, each patient was 
given a daily food diary program including the list of 
antioxidant ingredients to determine the consumption 
of other antioxidants during the first 4 weeks.  
Table1. Nutritive value of dark chocolate 
Nutritional information of dark chocolate 100gr 
Energy value 507K cal 
protein 8.54gr 
Fat 31.8gr 
Carbohydrate 46.75gr 
Calcium 345.9mgr 
Sodium 44.76mgr 
 
Table2. Nutritive value of white chocolate 
Nutritional information of white chocolate 100gr 
Energy value 580K cal 
protein 12.5gr 
Fat 38gr 
Carbohydrate 43gr 
Calcium - 
Sodium 840mgr 
 
Clinical parameters measurement: Probing pocket 
depth (PPD), gingival index (GI, Silness and Loe), 
modified papillary bleeding index (MPBI, Barnett) and 
clinical attachment loss (CAL) were recorded at 
baseline and 2,4,6,8 weeks later in ramfjord teeth. 
Saliva sample collection: Saliva samples were 
collected from patients at baseline and on 28
th
 day of 
study. Patients rinsed their mouth with water for about 
one minute and then oral cavity was examined to 
insure there is not any debris or blood. Unstimulated 
saliva (2-3ml) was collected by using spitting. During 
saliva collection, patients seated comfortably and 
spitted saliva during 10 min. The saliva samples were 
collected and stored at -20 °C freezer. 
Biochemical parameters measurement 
Ferric reducing antioxidant power (FRAP) assay: 
FRAP test was used to determine TAC of saliva. The 
method estimates the ferric reducing ability in the 
presence of antioxidants. 
[25]
 FRAP reagent contains 
TPTZ (2, 4, 6-tripyridyl-s-triazine; sigma USA) 10 
mM in HCl (40mM);  FeCl3 (20 mM) and buffer 
acetate 0.3 M (PH, 3.6) in the ratio of 1:1:10; the 
reagent was newly provided and warmed for 5 min at 
37°C. The working FRAP reagent (1.5 ml) was mixed 
with 50µL of saliva. After 10 min at 37°C, the 
absorbance value was measured at 593 nm and 
compared with the standard value. FeSO4 (125, 250, 
500, and 1000μM) was assumed as the standard 
solution based on standard curve. 
Tiuborbituric acid reactive substances (TBARS) 
assay: TBARS test was used to estimate 
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Malondialdehyde of saliva that byproduct of lipid 
peroxidation.
[26] 
Working TBARS reagent consisted of 
Trichloroacetic acid, (15%W/V, Merck Germany), 
TBA(375%W/V, Sigma USA) and HCl 0/25 M (Sigma 
USA) was prepared. Working TBARS reagent (2 mL) 
was mixed whit of saliva (1 mL), warmed for 15 min at 
100 °C and then centrifuged at 1500 rpm for 10 min. 
Finally, the absorbance value was detected at 535 nm 
versus with the blank absorbance concentration 
calculated by Beer-Lambert method.
[26]  
Statistical analysis: Data of clinical parameters were 
analyzed using t-test and repeated measures tests. 
Biochemical parameters were analyzed using t-test. 
The statistical difference was significant at p<0.05.  
 
 
Results 
 Forty patients participated in the present study and  
were divided into two groups. Treatment group (12 
women and 8 men, age 38.85±5.35) received dark 
chocolate and control group (14 women and 6 men, age 
39.85±6.16) received white chocolate. Intra-group 
comparison of PPD, GI, MPBI, CAL demonstrated 
significantly decrease in both groups (p<0.0001) and 
inter-group comparison showed significant decrease of 
MPBI in test group (p<0.03). MPBI and GI were 
significantly decreased in treatment group compared to 
the control in the 4
th
, 6th and 8th weeks of study, 
according to the t-test. (GI4, P=0.008-GI6, P=0.008-
GI8, P=0.009), MPB14, MPBI6, MPBI8, P<0.0001), 
(table 3). Mean difference of FRAP from baseline to 
4th week was 175.71±26.52µM in treatment group and 
14.21±17.0µM in control group. Mean difference of 
TBARS from baseline to 4th week was 0.11±0.01µM 
in test group and 0.05±0.01µM in control group (figure 
1), (figure 2). Treatment group showed the increase in 
FRAP (p<0.00001) and decrease in TBARS (P<0.015) 
were statically significant in compare with control group. 
Table 3. Mean ±(SD) of clinical parameters at baseline and in the 4
th
 ,6
th
 and 8
th
 weeks  
  week 8  week 6 week 4  week 2 Base line Clinical parameters 
2.29±0.40 2.31±0.39 2.35±0.38 2.46±0.36 2.54±0.34 Treatment group PPD 
2.38±0.36 2.40±0.37 2.41±0.35 2.45±0.36 2.48±0.37 Control group 
NS NS NS NS NS* P. Value 
0.87±0.28 0.90±0.30 1±0.29 1.29±0.28 1.52±0.29 Treatment group GI 
1.12±0.27 1.17±0.28 1.26±0.28 1.39±0.28 1.50±0.29 Control group 
P=0.009 P=0.008 P=0.008 NS NS P. Value 
0.72±0.32 0.84±0.32 0.99±0.30 1.39±0.26 1.70±0.25 Treatment group MPBI 
1.06±0.25 1.17±0.23 1.29±0.25 1.49±0.25 1.64±0.26 Control group 
P<0.001 P<0.001 P<0.001 NS NS P. Value 
3.35±0.37 3.36±0.36 3.36±0.37 3.49±0.35 3.55±0.35 Treatment group CAL 
3.31±0.25 3.32±0.25 3.37±0.25 3.42±0.23 3.44±0.23 Control group 
NS NS NS NS NS P. Value 
NS*: Not Significant 
 
 
 
 
 
 
 
 
 
 
 
 
Figure1. FRAP mean±(SEM) at baseline and on 
28th day of study in treatment and test groups (The 
number of subjects in each group was 20) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure2. TBARS mean±(SEM) at baseline and on 
28th day of study in treatment and test groups (The 
number of subjects in each group was 20) 
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Discussion 
According to the present study, the daily 
consumption of 30 gr dark chocolate (78% cocoa) for 4 
weeks compared to consumed 22.5 gr white chocolate 
could significantly increase TAC and decrease lipid 
peroxidation of saliva. These results may be due to the 
phenolic compounds of dark chocolate that works as 
antioxidants.  There is statically significant decrease in 
PPD, MPBI, GI and CAL in both groups during all 
study periods that shows the positive effects of oral 
hygiene instruction and SRP on improvement of 
chronic moderate periodontitis. Comparing the data of 
clinical parameters between two groups exhibited 
consumption of dark chocolate caused significant 
decrease of gingival inflammation and bleeding. This 
effect is not significant in PPD and CAL that may be 
due to inadequate dosage and duration of cocoa 
consumption. Inflammation and bleeding are the first 
signs of periodontal disease and according to these 
results cocoa as an anti-inflammatory compound can 
decrease them. 
Although similar study evaluated the effect of 
cocoa on TAC and lipid peroxidation in saliva was not 
found, there were some studies evaluated the effect of 
cocoa on these two factors in serum or plasma. Rein et 
al. 
[27]
 and Wang et al. 
[28]
 indicated that chocolate 
consumption was effective on the increase and 
decrease of plasma antioxidant capacity and plasma 
lipid peroxidation, respectively. In addition, the studies 
of Wan et al. 
[29] 
and Serafini et al. 
[30]
 displayed cocoa 
consumption could increase serum TAC. Mursu et al. 
[31]
 showed that long-term (3 weeks) use of dark 
chocolate had positive effects on one of the markers of 
lipid peroxidation. Fraga et al. 
[32]
 revealed that 
chocolate consumption decrease plasma level of MDA. 
Herman et al. 
[33]
 suggested that dark chocolate 
consumption increased FRAP in plasma. All of these 
findings were the same as those of present study. On 
the other hand, some of investigations demonstrated 
different results. Osakabe et al. 
[34]
 pointed out the daily 
consumption of 36 gr cocoa powder for 2 weeks by 15 
subjects showed no significant changes in plasma level 
of lipid or antioxidants. Furthermore, Mathur et al. 
[35]
 
demonstrated that the daily consumption of cocoa 
products for 6 weeks had not influenced on plasma 
antioxidant capacity. The research of Engler et al. 
[36]
 
indicated that the daily consumption of 46 gr dark 
chocolate for 2 weeks could not change plasma TAC. 
Vlachopoulos et al. 
[37]
 research determined single 
dosage (100 gr) of dark chocolate use could not alter 
MDA and TAC in plasma. In these studies the sample 
size or dosage and duration of cocoa consumption were 
less than current study and samples were not collected 
from saliva. In an animal study, the preventive effects 
of cocoa-enriched diet on gingival oxidative stress in 
experimental periodontitis had been investigated. It 
was shown that cocoa could decrease gingival 
oxidative stress and inhibit bone loss and leukocyte 
infiltration so this pant prevented the progression of 
periodontitis. 
[8]
 Also, the results of this current study 
showed that cocoa could result in improvement and 
prevention of periodontitis. No study in which the 
effects of cocoa on periodontitis clinical parameters 
were evaluated was found but some other research 
investigated other phenolic compound such as green 
tea. Green tea was used in different delivery ways such 
as strip (Jenabian et al, 2012) and mouthwash (Kudva 
et al, 2011). 
[38,39]
 These studies suggested the positive 
effects of green tea because of its phenolic base 
ingredients so it can be concluded that the herbal 
compounds such as cocoa and green tea are useful in 
improving the periodontal inflammation. 
 The strength of this study was to assess the 
salivary parameters beside clinical measurements but 
the limitations of this study were the difficulty of 
managing dietary schedule of subjects and also no 
possibility to use the same weight for dark and white 
chocolate. For further knowledge, the measuring of 
gingival crevicular fluid antioxidant capacity and lipid 
peroxidation is suggested by authors Jenabian et al, 
2012 
Conclusion   
Consuming dark chocolate could increase TAC and 
decrease lipid peroxidation, gingival bleeding and 
inflammation. 
 
 
Acknowledgements 
We thank to the staff of the department of 
periodontology and biochemistry laboratory, Babol 
University of Medical Sciences. This investigation was 
supported by Council of Research and Technology of 
Babol University of Medical Sciences. 
 
Funding: This study was a part of thesis and research 
project (Grant No: 9236329) supported and funded by 
Babol University of Medical Sciences. 
Conflict of interest:  There is no conflict of interest. 
D
ow
nl
oa
de
d 
fro
m
 c
jdr
.ir 
at 
13
:36
 +0
33
0 o
n W
ed
ne
sd
ay
 D
ec
em
be
r 1
2th
 20
18
    
    
  [ 
DO
I: 1
0.2
20
88
/cj
dr.
4.1
.43
 ]  
 Effects of dark chocolate in chronic periodontitis 
 
 
Caspian J Dent Res-March 2015, 4(1):43-49                                                          48 
References 
1. Marchetti E, Monaco A, Procaccini L, Mummolo S, 
Gatto R, Tetè S, et al. Periodontal disease: the 
influence of metabolic syndrome. Nutr Metab 
(Lond)  2012;9:88. 
2. Chapple IL, Milward MR, Dietrich T. The 
prevalence of inflammatory periodontitis is 
negatively associated with serum antioxidant 
concentrations. J Nutr 2007;137:657-64. 
3. Žilinskas J, Kubilius R, Žekonis G, Žekonis J. Total 
antioxidant capacity of venous blood, blood 
plasma, and serum of patients with periodontitis, 
and the effect of Traumeel S on these 
characteristics. Medicina (Kaunas) 2011;47:193-9. 
4. Borges I Jr, Moreira EA, Filho DW, de Oliveira TB, 
da Silva MB, Fröde TS. Proinflammatory and 
oxidative stress markers in patients with 
periodontal disease. Mediators Inflamm 
2007;2007:45794. 
5. Palaska I, Papathanasiou E, Theoharides TC. Use of 
polyphenols in periodontal inflammation. Eur J 
Pharmacol 2013;720:77-83. 
6. Elgendy EA, Ali SA, Zineldeen DH. Effect of local 
application of tea tree (Melaleuca alternifolia) oil 
gel on long pentraxin level used as an adjunctive 
treatment of chronic periodontitis: A randomized 
controlled clinical study. J Indian Soc Periodontol 
2013;17:444-8. 
7. Chandra RV, Srinivas G, Reddy AA, Reddy BH, 
Reddy C, Nagarajan S, et al. Locally delivered 
antioxidant gel as an adjunct to nonsurgical therapy 
improves measures of oxidative stress and 
periodontal disease. J Periodontal Implant Sci 
2013;43:121-9. 
8. Tomofuji T, Ekuni D, Irie K, Azuma T, Endo Y, 
Tamaki N, et al. Preventive effects of a cocoa-
enriched diet on gingival oxidative stress in 
experimental periodontitis. J Periodontol 
2009;80:1799-808. 
9. Grassi D, Desideri G, Ferri C. Blood pressure and 
cardiovascular risk: what about cocoa and 
chocolate? Arch Biochem Biophys 2010;501:112-5. 
10. Galleano M, Oteiza PI, Fraga CG. Cocoa, chocolate 
and cardiovascular disease. J Cardiovasc Pharmacol 
2009;54: 483–90. 
11. Corti R, Flammer AJ, Hollenberg NK, Lüscher TF. 
Cocoa and cardiovascular health. Circulation 
2009;119:1433-41. 
12. Mao TK, Van de Water J, Keen CL, Schmitz HH, 
Gershwin ME. Effect of cocoa flavanols and their 
related oligomers on the secretion of interleukin-5 
in peripheral blood mononuclear cells. J Med Food 
2002;5:17-22. 
13. Ferrazzano GF, Amato I, Ingenito A, De Natale A, 
Pollio A. Anti-cariogenic effects of polyphenols 
from plant stimulant beverages (cocoa, coffee, tea). 
Fitoterapia 2009;80:255-62. 
14. Fernández-Murga L, Tarín JJ, García-Perez MA, 
Cano A. The impact of chocolate on cardiovascular 
health. Maturitas 2011;69:312-21. 
15. Martin MA, Goya L, Ramos S. Potential effects of 
cocoa and cocoa polyphenols in cancer. Food Chem 
Toxicol 2013;56:336-51. 
16. Sakagami H, Kawano M, Thet MM, Hashimoto K, 
Satoh K, Kanamoto T, et al. Anti-HIV and 
immunomodulation activities of cacao mass lignin-
carbohydrate complex. In Vivo 2011;25:229-36. 
17. Sudano I, Flammer AJ, Roas S, Enseleit F, 
Ruschitzka F, Corti R, et al. Cocoa, Blood Pressure, 
and Vascular Function. Curr Hypertens Rep 
2012;14:279-84. 
18. Sokolov AN, Pavlova MA, Klosterhalfen S, Enck 
P. Chocolate and the brain: Neurobiological impact 
of cocoa flavanols on cognition and behavior. 
Neurosci Biobehav Rev 2013;37:2445–53. 
19. Nehlig A. The neuroprotective effects of cocoa 
flavanol and its influence on cognitive 
performance. Br J Clin Pharmacol 2013;75:716-27. 
20. Pérez-Cano FJ, Massot-Cladera M, Franch A, 
Castellote C, Castell M. The effect of cocoa on the 
immune system. Front Pharmacol 2013;4:71. 
21. Heinrich U, Neukam K, Tronnier H, Sies H, Stahl 
W. Long-Term Ingestion of High Flavanol Cocoa 
Provides Photoprotection against UV-Induced 
Erythema and Improves Skin Condition in Women. 
J Nutr 2006;136:1565-9. 
22. Baltacıoğlu E, Yuva P, Aydın G, Alver A, 
Kahraman C, Karabulut E, et al. Lipid Peroxidation 
Levels and Total Oxidant/Antioxidant Status in 
Serum and Saliva From Patients With Chronic and 
Aggressive Periodontitis. Oxidative Stress Index: A 
New Biomarker for Periodontal Disease? J 
Periodontol2014; 85:1432-41.  
23. Novakovic N, Todorovic T, Rakic M, Milinkovic I, 
Dozic I, Jankovic S, et al. Salivary antioxidants as 
periodontal biomarkers in evaluation of tissue 
D
ow
nl
oa
de
d 
fro
m
 c
jdr
.ir 
at 
13
:36
 +0
33
0 o
n W
ed
ne
sd
ay
 D
ec
em
be
r 1
2th
 20
18
    
    
  [ 
DO
I: 1
0.2
20
88
/cj
dr.
4.1
.43
 ]  
 Roodgaryan  R, et al. 
 
49                                                         Caspian J Dent Res-March 2015, 4(1):43-49 
status and treatment outcome. J Periodontal Res 
2014;49:129-36. 
24. Miricescu D, Totan A, Calenic B, Mocanu B, 
Didilescu A, Mohora M, et al. Salivary biomarkers: 
relationship between oxidative stress and alveolar 
bone loss in chronic periodontitis. Acta Odontol 
Scand 2014,72:42-7.  
25. Dehghan Gh, Ebrahimi S, Shaghaghi S, Jafari A, 
Mohammadi M, Badalzade R, et al. Antioxidant 
effect of cinnamon bark extract following an 
exhaustive exercises in male rats. J Babol Univ 
Med Sci 2011;13:21-6.[In Persian] 
26. Lakzaei M, Pouramir M, Zabihi E, Moghadamnia 
AA. Preventive effects of pyrus biossierana bushes 
leaves extract on lipid and protein oeroxidation in 
hyperglycemic rats. J Babol Univ Med Sci 
2012;15:21-9 .[In Persian] 
27. Rein D, Lotito S, Holt RR, Keen CL, Schmitz HH, 
Fraga CG. Epicatechin in human plasma: in vivo 
determination and effect of chocolate consumption 
on plasma oxidation status. J Nutr 2000; 
130:2109S-14S. 
28. Wang JF, Schramm DD, Holt RR, Ensunsa JL, 
Fraga CG, Schmitz HH, et al. A dose-response 
effect from chocolate consumption on Plasma 
epicatechin and oxidative damage. J Nutr 
2000;130:2115S-9S. 
29. Wan Y, Vinson JA, Etherton TD, Proch J, Lazarus 
SA, Kris-Etherton PM. Effects of cocoa powder 
and dark chocolate on LDL oxidative susceptibility 
and prostaglandin concentrations in humans. Am J 
Clin Nutr 2001;74:596-602. 
30. Serafini M, Bugianesi R, Maiani G, Valtuena S, De 
Santis S, Crozier A. Plasma antioxidants from 
chocolate. Nature 2003;424:1013. 
31. Mursu J, Voutilainen S, Nurmi T, Rissanen TH, 
Virtanen JK, Kaikkonen J, et al. Dark Chocolate 
Consumption increases HDL cholesterol 
concentration and chocolate fatty acids may inhibit 
lipid Peroxidation in healthy humans. Free Radic 
Biol Med 2004; 37:1351-9. 
32. Fraga CG, Actis-Goretta L, Ottaviani JI, 
Carrasquedo F, Lotito SB, Lazarus S, et al. Regular 
consumption of a flavanol-rich chocolate can 
improve oxidant stress in young soccer players. 
Clin Dev Immunol 2005;12:11-7. 
33. Hermann F, Spieker LE, Ruschitzka F, Sudano I, 
Hermann M, Binggeli C, et al. Dark chocolate 
improves endothelial and platelet function. Heart 
2006; 92:119-20. 
34. Osakabe N, Baba S, Yasuda A, Iwamoto T, 
Kamiyama M, Takizawa T, et al. Daily cocoa 
intake reduces the susceptibility of low-density 
lipoprotein to oxidation as demonstrated in healthy 
human volunteers. Free Radic Res 2001;34:93-9. 
35. Mathur S, Devaraj S, Grundy SM, Jialal I. Cocoa 
products decrease low density lipoprotein oxidative 
susceptibility but do not affect biomarkers of 
inflammation in humans. J Nutr 2002;132:3663-7. 
36. Engler MB, Engler MM, Chen CY, Malloy MJ, 
Browne A, Chiu EY, et al. Flavonoid-rich dark 
chocolate improves endothelial function and 
increases plasma epicatechin concentrations in 
healthy adults. J Am Coll Nutr 2004;23:197-204. 
37. Vlachopoulos C, Aznaouridis K, Alexopoulos N, 
Economou E, Andreadou I, Stefanadis C.Effect of 
dark chocolate on arterial function in healthy 
individuals. Am J Hypertens 2005;18:785-91. 
38. Jenabian N, Moghadamnia AA, Karami E, Mir A 
PB. The effect of Camellia Sinensis (green tea) 
mouthwash on plaque-induced gingivitis: a single-
blinded randomized controlled clinical trial. Daru 
2012;20:39. 
39. Kudva P, Tabasum ST, Shekhawat NK. Effect of 
green tea catechin, a local drug delivery system as 
an adjunct to scaling and root planing in chronic 
periodontitis patients: A clinicomicrobiological 
study. J Indian Soc Periodontol 2011;15:39-45. 
 
D
ow
nl
oa
de
d 
fro
m
 c
jdr
.ir 
at 
13
:36
 +0
33
0 o
n W
ed
ne
sd
ay
 D
ec
em
be
r 1
2th
 20
18
    
    
  [ 
DO
I: 1
0.2
20
88
/cj
dr.
4.1
.43
 ]  
